FORM 10-Q


                       SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549

(Mark One)

[X]       QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 1997

                                       OR

[  ]      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934

For the transition period from.............to.....................

Commission file number 1-225

                           KIMBERLY-CLARK CORPORATION
             (Exact name of registrant as specified in its charter)

         Delaware                                            39-0394230
    (State or other jurisdiction of                          (I.R.S. Employer
    incorporation or organization)                           Identification No.)


                                P. O. Box 619100
                                Dallas, Texas
                                   75261-9100
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (972) 281-1200
              (Registrant's telephone number, including area code)

                                   No change
   (Former name, former address and former fiscal year, if changed since last
                                    report)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

Yes    X  .  No       .


As of August 4, 1997, 556,693,095 shares of the Corporation's common stock were
outstanding.




                          PART I - FINANCIAL INFORMATION

Item 1.  Financial Statements.


CONSOLIDATED INCOME STATEMENT KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES Three Months Six Months Ended June 30 Ended June 30 --------------------- --------------------- (Millions of dollars except per share amounts) 1997 1996 1997 1996 - ---------------------------------------------------------------------------------------------------------------- Net Sales .................................... $3,124.3 $3,347.7 $6,361.9 $6,549.8 Cost of products sold ................... 1,932.1 2,093.4 3,928.7 4,127.4 -------- -------- -------- -------- Gross Profit ............................. 1,192.2 1,254.3 2,433.2 2,422.4 Advertising, promotion and selling expenses ............................. 485.5 565.2 983.8 1,065.3 Research expense ........................ 50.3 51.4 99.0 97.0 General expense ......................... 162.0 149.5 311.7 278.6 -------- -------- -------- -------- Operating Profit ............................. 494.4 488.2 1,038.7 981.5 Interest income ......................... 10.0 7.2 18.6 14.7 Interest expense ......................... (40.0) (50.5) (83.3) (102.1) Other income (expense), net ............. .9 73.1 9.6 72.4 -------- -------- -------- -------- Income Before Income Taxes ................... 465.3 518.0 983.6 966.5 Provision for income taxes .............. 153.6 181.4 324.6 338.3 -------- -------- -------- -------- Income Before Equity Interests ............... 311.7 336.6 659.0 628.2 Share of net income of equity companies .. 51.2 37.9 83.7 72.8 Minority owners' share of subsidiaries' net income ........................... (12.1) (9.8) (27.7) (21.5) -------- -------- -------- -------- Income Before Extraordinary Gains ............ 350.8 364.7 715.0 679.5 Extraordinary gains, net of income taxes . 12.7 - 17.5 - -------- -------- -------- -------- Net Income.................................... $ 363.5 $ 364.7 $ 732.5 $ 679.5 ========= ========= ========= ========= Per Share Basis: Income before extraordinary gains ........ $ .63 $ .64 $ 1.28 $ 1.20 Extraordinary gains, net of income taxes...... .02 - .03 - --------- --------- --------- --------- Net Income ............................... $ .65 $ .64 $ 1.31 $ 1.20 ========= ========= ========= ========= Cash Dividends Declared .................. $ .24 $ .23 $ .48 $ .46 ========= ========= ========= =========
Unaudited See Notes to Financial Statements. 2
CONDENSED CONSOLIDATED BALANCE SHEET KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES June 30, December 31, (Millions of dollars) 1997 1996 - ------------------------------------------------------------------------------------- ASSETS Current Assets Cash and cash equivalents ................... $ 90.0 $ 83.2 Accounts receivable ......................... 1,602.5 1,660.9 Inventories ................................. 1,319.9 1,348.3 Other current assets ........................ 295.0 446.8 ----------- ------------ Total Current Assets ..................... 3,307.4 3,539.2 Property ....................................... 10,272.0 11,927.2 Less accumulated depreciation ............... 4,290.4 5,113.9 ----------- ------------ Net Property ............................. 5,981.6 6,813.3 Investments in Equity Companies ................ 577.6 551.1 Goodwill, Deferred Charges and Other Assets .... 984.6 942.1 Assets Held for Sale ........................... 275.4 - ----------- ----------- $ 11,126.6 $ 11,845.7 =========== =========== LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Debt payable within one year ................ $ 239.0 $ 576.5 Accounts payable ............................ 924.0 1,119.3 Accrued expenses ............................ 1,417.0 1,460.1 Other current liabilities ................... 537.1 531.0 ----------- ----------- Total Current Liabilities ................ 3,117.1 3,686.9 Long-Term Debt ................................. 1,668.2 1,738.6 Noncurrent Employee Benefit and Other Obligations 888.5 926.1 Deferred Income Taxes .......................... 622.9 762.3 Minority Owners' Interests in Subsidiaries ..... 212.4 248.7 Stockholders' Equity ........................... 4,617.5 4,483.1 ----------- ----------- $ 11,126.6 $ 11,845.7 =========== ===========
Unaudited See Notes to Financial Statements. 3
CONDENSED CONSOLIDATED CASH FLOW STATEMENT KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES Six Months Ended June 30 --------------------- (Millions of dollars) 1997 1996 - ----------------------------------------------------------------------------------- Operations Net Income............................................ $ 732.5 $ 679.5 Depreciation.......................................... 242.0 279.1 Deferred income tax provision......................... 218.1 57.9 Changes in operating working capital.................. (471.3) (201.3) Extraordinary gains, net of income taxes.............. (17.5) - Net gains on asset dispositions....................... - (62.9) Pension funding (in excess of) less than expense...... (5.0) 4.0 Other................................................. (47.3) (58.7) -------- --------- Cash Provided by Operations........................ 651.5 697.6 -------- --------- Investing Capital spending...................................... (442.0) (335.6) Acquisition of businesses, net of cash acquired....... (54.9) (68.0) Disposals of property and businesses.................. 742.6 265.5 Other................................................. (36.2) .1 -------- --------- Cash Provided by (Used for) Investing.............. 209.5 (138.0) -------- --------- Financing Cash dividends paid................................... (263.9) (202.3) Changes in short-term debt ........................... (229.9) (308.5) Increases in long-term debt........................... 70.1 19.9 Decreases in long-term debt........................... (183.8) (114.8) Proceeds from exercise of stock options............... 32.4 157.9 Acquisitions of common stock for the treasury......... (287.4) (243.9) Other................................................. 8.3 6.4 -------- --------- Cash Used for Financing............................ (854.2) (685.3) -------- --------- Increase (Decrease) in Cash and Cash Equivalents......... $ 6.8 $ (125.7) ======== =========
Unaudited See Notes to Financial Statements. 4 NOTES TO FINANCIAL STATEMENTS KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES 1. The unaudited consolidated financial statements of Kimberly-Clark Corporation (the 'Corporation') have been prepared on the same basis as those in the 1996 Annual Report to Stockholders and include all adjustments necessary to present fairly the condensed consolidated balance sheet and consolidated income and condensed cash flow statements for the periods indicated. 2. Share of net income of equity companies for the quarter and six months ended June 30, 1997 includes a net nonoperating gain of $16.3 million, or $.03 per share, primarily related to the sale of a portion of the tissue business of Kimberly-Clark de Mexico, S.A. de C.V. ('KCM'). The sale was required by the Mexican regulatory authorities following the 1996 merger of KCM and Scott Paper Company's ('Scott') former Mexican affiliate. 3. In June 1997, the Corporation sold its interest in Scott Paper Limited ('SPL'), a 50.1 percent-owned Canadian tissue subsidiary. The sale resulted in a gain of $12.7 million, or $.02 per share, which has been reported as an extraordinary item. In March 1997, the Corporation sold its Coosa Pines, Alabama, newsprint and pulp manufacturing mill, together with related woodlands. In the first quarter of 1997, the Corporation recorded impairment losses on the planned sales of a pulp manufacturing mill in Miranda, Spain; a recycled fiber facility in Oconto Falls, Wisconsin; and a tissue converting facility in Yucca, Arizona; and on an integrated pulp making facility in Everett, Washington. These first quarter 1997 transactions were aggregated and reported together with the SPL gain as extraordinary gains totaling $17.5 million, or $.03 per share, for the six months ended June 30, 1997. 4. Other income (expense), net for the quarter and six months ended June 30, 1996 includes net gains of approximately $70 million in asset disposals. The net gains relate to the divestiture of the former Scott baby wipes and certain facial tissue businesses in the U.S., as required to meet regulatory requirements for the 1995 merger of Kimberly-Clark and Scott, and the sale of the Corporation's remaining 20 percent interest in Midwest Express Airlines. The net income effect of these gains was $.08 per share. 5. The average number of common shares outstanding for the six months ended June 30, 1997 and 1996 was 560.1 million and 564.0 million, respectively. The number of common shares outstanding as of June 30, 1997 and 1996 was 559.3 million and 563.3 million, respectively. 6. The following schedule details inventories by major class as of June 30, 1997 and December 31, 1996: June 30, December 31, (Millions of dollars) 1997 1996 - ----------------------------------------------------------------------------- At lower of cost on the First-In, First-Out (FIFO) method or market: Raw materials ........................... $ 346.5 $ 363.7 Work in process ......................... 208.0 219.7 Finished goods .......................... 820.3 803.6 Supplies and other ...................... 183.7 201.7 -------- -------- 1,558.5 1,588.7 Excess of FIFO cost over Last-In, First-Out (LIFO) cost .................. (238.6) (240.4) -------- -------- Total .................................. $1,319.9 $1,348.3 ======== ======== Unaudited 5 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. Management believes that the following commentary and tables appropriately discuss and analyze the comparative results of operations and the financial condition of the Corporation for the periods covered. RESULTS OF OPERATIONS: Second Quarter of 1997 Compared With Second Quarter of 1996
By Business Segment ($ Millions) % Change % of 1997 Net Sales 1997 vs. 1996 Consolidated - ------------------------------------------------------------------- Personal Care Products......... $1,325.1 +10.6% 42.3% Tissue-Based Products.......... 1,633.0 -15.1 52.3 Newsprint, Paper and Other..... 176.8 -28.5 5.7 Adjustments.................... (10.6) (.3) -------- ----- Consolidated................... $3,124.3 - 6.7% 100.0% ======== =====
% Change % of 1997 % Return on Sales ----------------- Operating Profit 1997 vs. 1996 Consolidated 1997 1996 - ------------------------------------------------------------------------------------- Personal Care Products ........ $ 249.3 +36.2% 50.4% 18.8% 15.3% Tissue-Based Products ......... 206.8 -18.3 41.8 12.7 13.2 Newsprint, Paper and Other .... 43.9 -30.9 8.9 24.8 25.7 Adjustments.................... (5.6) (1.1) ------- ----- Consolidated................... $ 494.4 + 1.3% 100.0% 15.8% 14.6% ======= =====
Commentary: Net sales declined 6.7 percent principally because of the loss of revenues from businesses that were divested in 1996 to satisfy U.S. and European regulatory requirements associated with the Scott Paper Company ('Scott') merger transaction (the former Scott baby wipes and certain tissue businesses) and businesses that were sold in 1997 (the Corporation's 50.1 percent interest in Scott Paper Limited ('SPL'), a Canadian tissue business, and a newsprint and pulp manufacturing operation at Coosa Pines, Alabama ('Coosa')). Excluding the second quarter sales of these businesses in both years ($62.1 million in 1997 and $257.7 million in 1996), consolidated net sales were down approximately 1 percent, but sales volumes increased nearly 2 percent. The following sales comparisons exclude divested businesses. . Worldwide sales of personal care products increased more than 14 percent, and sales volumes grew almost 19 percent. Important contributors to the improved sales volumes were training and youth pants, disposable diapers, wet wipes and professional health care products in North America and disposable diapers in Europe and Latin America. Acquisitions in France, Spain and Brazil contributed to the diaper volume increase. 6 . Sales volumes of tissue-based products were down 9 percent worldwide. Sales volumes of both consumer tissue and away-from-home products in North America declined approximately 4 percent compared to the second quarter of 1996. Sales volumes for these products in Europe were down significantly when compared to the exceptionally strong sales volumes in the second quarter of 1996. . On an overall basis, selling prices were approximately 1 percent lower than in the second quarter of 1996. . Changes in currency exchange rates reduced consolidated net sales approximately 2 percent in the second quarter of 1997. Gross profit declined 5.0 percent in absolute terms, but improved to 38.2 percent from 37.5 percent as a percentage of sales. Operating profit improved 1.3 percent in absolute terms, and to 15.8 percent from 14.6 percent as a percentage of net sales. Despite the lower selling prices, the operating margin improvement was achieved as a result of the sales volume increases, manufacturing efficiencies, lower pulp costs, merger synergies and reduced promotion expense. Excluding the divested businesses, operating profit increased nearly 8 percent. . Cost reductions and manufacturing efficiencies were achieved in the North American personal care businesses. . Operating profit for the North American away-from-home business declined approximately $35 million reflecting strategic changes in the combination of Kimberly-Clark's and Scott's away-from-home businesses. The changes are intended to improve the profitability of this business over the long-term by focusing on value-added, branded strategies. In the near-term, however, the transition has resulted in lower sales and higher costs, with a negative impact on operating profit. . North American tissue businesses and certain personal care businesses had lower promotion expenses in connection with the lower selling prices. In addition, divested businesses had a favorable effect on the year-to-year marketing cost comparison. . General expenses were higher principally as a result of business expansions outside North America. . Changes in currency exchange rates reduced consolidated operating profit approximately 1 percent in the second quarter of 1997. 7
By Geography ($ Millions) % Change % of 1997 Net Sales 1997 vs. 1996 Consolidated - ------------------------------------------------------------ North America............. $2,107.4 -5.9% 67.5% Outside North America..... 1,092.6 -8.6 35.0 Adjustments............... (75.7) (2.5) -------- ----- Consolidated.............. $3,124.3 -6.7% 100.0% ======== =====
% Change % of 1997 % Return on Sales ------------------ Operating Profit 1997 vs. 1996 (a) Consolidated 1997 1996 (a) - ------------------------------------------------------------------------------------- North America............. $409.7 +1.7% 82.8% 19.4% 18.0% Outside North America..... 90.3 -6.9 18.3 8.3 8.1 Adjustments............... (5.6) (1.1) ------ ----- Consolidated.............. $494.4 +1.3% 100.0% 15.8% 14.6% ====== =====
(a) Certain 1996 data has been reclassified to conform to the 1997 presentation. Commentary: . Excluding the divested businesses, operating profit improved 6.9 percent in North America and 3.1 percent outside North America. . Operating profit in Europe decreased due to the decline in sales volumes of tissue-based products offset, in part, by sales volume increases for disposable diapers, lower pulp costs, merger synergies and reduced promotion expense. . Operating profit was higher in Latin America, primarily as a result of business expansion in Brazil in July 1996. Additional Income Statement Commentary: . The decline in interest expense is attributable to lower average debt levels. . Other income in 1996 includes a net pretax gain of approximately $70 million related to the divestiture of businesses to meet the U.S. regulatory requirements for the Scott merger, and the sale of the Corporation's remaining 20 percent interest in Midwest Express Holdings, Inc., the parent company of Midwest Express Airlines, Inc. These transactions resulted in an after-tax gain of $.08 per share. . The effective income tax rate decreased to 33.0 percent from 35.0 percent in the prior year and is expected to remain at or below 33.0 percent for the balance of 1997. The lower effective tax rate is primarily due to additional tax planning opportunities, some of which arose from the Scott merger. . The Corporation's 1997 share of net income of equity companies includes a net nonoperating gain of $16.3 million, equal to $.03 per share, comprised primarily of a gain from the sale of a portion of the tissue business of Kimberly-Clark de Mexico, S.A. de C.V. ('KCM'). The Mexican Federal Commission of Competition required the sale in connection with its approval of KCM's 1996 merger with Scott's former Mexican affiliate. Excluding the net gain, the Corporation's share of equity company net income declined 7.9 percent. The decline is attributable to KCM where sales and earnings continue to be depressed by adverse economic conditions in Mexico. Although second quarter 1997 earnings at KCM were lower than a year ago, they were higher than the first quarter of 1997. 8 . On June 6, 1997, the Corporation completed the sale of its interest in SPL to Kruger Inc., a Canadian paper and forest products company, for approximately $127 million. APB 16, 'Business Combinations', requires that certain transactions occurring within two years following a business combination that was accounted for as a pooling of interests, and that were not planned at the date of combination, be reported as extraordinary items. Because the Scott merger occurred on December 12, 1995, in a pooling of interests transaction, the gain on the SPL sale has been reported as an extraordinary gain totaling $12.7 million, net of applicable income taxes of $22.4 million. The high effective income tax rate on the extraordinary item is due to the tax basis in SPL being substantially lower than the carrying amount of the investment in the financial statements. The extraordinary gain was equal to $.02 per share. . Excluding the Corporation's share of the previously discussed gain on the sale of a portion of the tissue business of KCM, the extraordinary gain on the sale of SPL and the 1996 gains on asset disposals, net income per share for the second quarter of 1997 increased 7.1 percent to $.60 from $.56 in the second quarter of 1996. 9 RESULTS OF OPERATIONS: First Six Months of 1997 Compared With First Six Months of 1996
By Business Segment ($ Millions) % Change % of 1997 Net Sales 1997 vs. 1996 Consolidated - --------------------------------------------------------------------- Personal Care Products.... $2,587.8 +10.5% 40.7% Tissue-Based Products..... 3,398.0 -9.1 53.4 Newsprint, Paper and Other 401.3 -20.6 6.3 Adjustments............... (25.2) (.4) -------- ----- Consolidated.............. $6,361.9 -2.9% 100.0% ======== =====
% Change % of 1997 % Return on Sales ------------------ Operating Profit 1997 vs. 1996 Consolidated 1997 1996 - ------------------------------------------------------------------------------------- Personal Care Products .. $ 500.1 +37.2% 48.1% 19.3% 15.6% Tissue-Based Products ... 460.6 -11.9 44.3 13.6 14.0 Newsprint, Paper and Other 84.7 -27.9 8.2 21.1 23.3 Adjustments.............. (6.7) (.6) --------- ----- Consolidated............. $ 1,038.7 + 5.8% 100.0% 16.3% 15.0% ========= =====
Commentary: Net sales declined 2.9 percent because of the loss of revenues from the businesses that were divested in 1996 to satisfy U.S. and European regulatory requirements associated with the Scott merger and businesses that were sold in 1997. Excluding the six-month sales of these businesses in both years ($259.0 million in 1997 and $527.0 million in 1996), consolidated net sales increased 1.3 percent, and sales volumes increased 6.2 percent. The following sales comparisons exclude divested businesses. . Worldwide sales of personal care products increased more than 14 percent, and sales volumes grew almost 19 percent. Important contributors to the improved sales volumes were training and youth pants, disposable diapers, wet wipes, professional health care products, and feminine care and adult care products in North America and disposable diapers in Europe and Latin America. Acquisitions in France, Spain and Brazil contributed to the diaper volume increase. . Despite higher sales volumes of tissue-based products in the U.S., Latin America and the Asia/Pacific region, worldwide sales volumes of these products declined about 1 percent due to exceptionally strong sales volumes in Europe in 1996. . On an overall basis, selling prices were approximately 3 percent lower than in the first six months of 1996, with North American consumer tissue experiencing the largest decline. 10 . Changes in currency exchange rates reduced consolidated net sales approximately 1.5 percent in the first six months of 1997. Gross profit improved .4 percent in absolute terms, and to 38.2 percent from 37.0 percent as a percentage of sales. Operating profit improved 5.8 percent in absolute terms, and to 16.3 percent from 15.0 percent as a percentage of net sales. Despite the lower selling prices, these margin improvements were achieved as a result of the sales volume increases, manufacturing efficiencies, lower pulp costs, merger synergies and reduced promotion expense. Excluding the divested businesses, operating profit increased nearly 13 percent. . Cost reductions and manufacturing efficiencies were achieved in the North American personal care businesses. . Operating profit for the North American away-from-home business declined approximately $52 million reflecting the near-term negative effects of the previously described strategic changes in the combination of Kimberly- Clark's and Scott's away-from-home businesses. . Divested businesses had a favorable effect on the year-to-year marketing cost comparison. . General expenses were higher principally as a result of business expansions outside North America. . Changes in currency exchange rates had no significant effect on consolidated operating profit in the first six months of 1997. 11
By Geography ($ Millions) % Change % of 1997 Net Sales 1997 vs. 1996 Consolidated - ------------------------------------------------------------- North America............. $ 4,359.3 -2.1% 68.5% Outside North America..... 2,172.5 -3.8 34.1 Adjustments............... (169.9) (2.6) --------- ----- Consolidated.............. $ 6,361.9 -2.9% 100.0% ========= =====
% Change % of 1997 % Return on Sales ------------------- Operating Profit 1997 vs. 1996 (a) Consolidated 1997 1996(a) - -------------------------------------------------------------------------------------- North America............. $ 865.1 +2.3% 83.2% 19.8% 19.0% Outside North America..... 180.3 +13.3 17.4 8.3 7.0 Adjustments............... (6.7) (.6) -------- ----- Consolidated.............. $1,038.7 + 5.8% 100.0% 16.3% 15.0% ======== =====
(a) Certain 1996 data has been reclassified to conform to the 1997 presentation. Commentary: . Excluding the divested businesses, operating profit improved 8.6 percent in North America and 22.7 percent outside North America. . Operating profit in Europe increased due to the sales volume increases for disposable diapers, lower pulp costs, merger synergies and reduced promotion expense offset, in part, by the previously mentioned lower sales volumes of tissue-based products . . Operating profit was higher in Latin America, primarily as a result of business expansion in Brazil in July 1996. Additional Income Statement Commentary: . The decline in interest expense is attributable to lower average debt levels. . Other income in 1996 includes a net pretax gain of approximately $70 million from the previously mentioned regulatory divestitures and the sale of the Corporation's remaining 20 percent interest in Midwest Express Holdings, Inc. . Excluding the Corporation's share of the previously discussed gain on the sale of a portion of the tissue business of KCM, the extraordinary gain on the sale of the Corporation's interest in SPL, the first quarter 1997 extraordinary gain on the sale of Coosa of $.01 per share and the 1996 gains on asset disposals, net income per share for the first six months of 1997 increased 11.6 percent to $1.25 from $1.12 for the first six months of 1996. 12 LIQUIDITY AND CAPITAL RESOURCES . Cash provided by operations in the first six months of 1997 was $651.5 million compared with $697.6 million in the first six months of 1996, a year- to-year decrease of $46.1 million. Net income plus non-cash charges included in net income increased to $1.1 billion in 1997 compared with $.9 billion in 1996. The Corporation invested more than $470 million in operating working capital in 1997 compared with approximately $200 million in 1996. Major uses of cash were higher tax payments arising, in part, from the Coosa and SPL sales, restructuring related payments and lower accounts payable. . At December 31, 1996, $423.1 million of the 1995 charge for the estimated costs of the Scott merger, for restructuring the combined operations and other unusual items (the ''one-time charge'') remained to be utilized. During the first six months of 1997, approximately $100 million of cash payments were charged to the reserves related to the one-time charge. The remaining reserves for restructuring and other unusual charges are estimated to be adequate to cover the planned actions contemplated in the one-time charge. . The cash provided by operations plus the proceeds from the sales of Coosa and SPL enabled the Corporation to reduce its outstanding debt to $1,907.2 million, a reduction of more than $400 million from the year-end 1996 level. . During the first six months of 1997, the Corporation repurchased 5.6 million shares of its common stock, including .6 million shares in the second quarter, at a total cost of nearly $280 million. The board of directors recently authorized the repurchase of an additional 2 million shares, raising the remaining authority for share repurchases to 7.8 million. . The first six months earnings, lower debt levels and repurchase of treasury shares combined to produce a ratio of total debt to capital of 28.3 percent at June 30, 1997 compared with 32.9 percent at December 31, 1996. The Corporation's objective is to maintain a total debt to capital ratio in the range of 30 to 40 percent. . The Corporation anticipates that it will continue to generate significant cash flow from operations. It also anticipates no difficulty in issuing debt in view of its excellent credit rating. Cash flow from operations plus the ability to issue both short-term and long-tem debt are believed to be sufficient to fund capital expenditures, pay dividends, meet debt maturity requirements, fund business acquisitions and continue to meet the Corporation's announced stock repurchase goals. 13 ENVIRONMENTAL MATTERS The Corporation has been named as a potentially responsible party at a number of waste disposal sites, none of which, individually or in the aggregate, in management's opinion, is likely to have a material adverse effect on its business or results of operations. ACCOUNTING PRONOUNCEMENTS NOT YET ADOPTED In February 1997, the FASB issued SFAS 128, 'Earnings per Share,' which will become effective at year-end 1997. Early adoption of the standard is not permitted. The pro-forma Basic Earnings per Share calculated pursuant to SFAS 128 for the second quarter and first six months of 1997 would be the same as reported Earnings per Share, and the pro-forma Diluted Earnings per Share calculated pursuant to SFAS 128 would not be materially lower than reported Earnings per Share. In June 1997, the FASB issued SFAS 130, 'Reporting Comprehensive Income' and SFAS 131, 'Disclosures about Segments of an Enterprise and Related Information'. Both standards become effective in 1998. Early adoption of SFAS 130 is permitted, and early adoption of SFAS 131 is encouraged. The effects of both of these standards on the Corporation are currently being determined. OUTLOOK Based on current business trends, management of the Corporation expects earnings per share from operations for the second half of 1997 will likely be in the same 'ballpark' as the first half of the year. In comparison with 1996, the Corporation's personal care businesses, particularly in North America and Latin America, are expected to continue to perform well. However, management's current view is that these positives will be offset by other factors. It is expected that results in the second half of 1997 will continue to be constrained by the conditions which are adversely affecting the Corporation's away-from-home operations and KCM. Further, operating profits in Europe may be impacted by price competition, which has recently intensified in several key consumer and away-from-home tissue markets, and by a step-up in advertising spending to support the launch of new and improved feminine care products. These negative issues are considered to be primarily transitional in nature. Management is taking steps to focus on profitable growth and reduce costs in the Corporation's away-from-home business, and KCM is showing signs of modest improvement. Management is also aggressively pursuing the sale of the Corporation's pulp operations in Terrace Bay, Ontario, New Glasgow, Nova Scotia and Miranda, Spain, which, as previously announced, are expected to be completed by mid-1998. As a result of these actions, earnings momentum is expected to become more positive in the fourth quarter of this year. Management continues to believe the Corporation has excellent potential for growth in its global markets and that it has the strategies in place to achieve its 'stretch' objective of doubling earnings from operations of $1.93 per share in 1995 to at least $3.86 per share in the year 2000. 14 INFORMATION CONCERNING FORWARD-LOOKING STATEMENTS Certain information contained in this report is forward looking and is based on various assumptions. Such information includes, without limitation, the business outlook, future capital resources, anticipated financial and operating results and contemplated transactions of the Corporation, the Corporation's estimated effective income tax rate in 1997, and the status and adequacy of the Corporation's remaining reserves for restructuring and other unusual charges at June 30, 1997. These forward-looking statements are based upon management's expectations and beliefs concerning future events impacting the Corporation. There can be no assurance that such events will occur or that their effects on the Corporation will be as currently expected. For a description of certain factors that could cause the Corporation's future results to differ materially from those expressed in any such forward-looking statements, see the section of Part I, Item 1 of the Corporation's Annual Report on Form 10-K for the year ended December 31, 1996 entitled 'Factors That May Affect Future Results.' 15 PART II - OTHER INFORMATION Item 1. Legal Proceedings Litigation Beginning in May 1997, numerous lawsuits have been filed in state and federal courts against the Corporation and other manufacturers of sanitary paper products sold in the away-from-home market. Plaintiffs, being direct and indirect purchasers of such products, allege that, beginning in 1993, defendants conspired to fix the prices for these products, causing plaintiffs to pay artificially inflated prices. Treble damages in an unspecified amount are being sought. Defendants have filed a motion to remove the state cases to federal court and a petition to consolidate the federal cases in multi-district litigation. Item 6. Exhibits and Reports on Form 8-K. (a) Exhibits (3)a Restated Certificate of Incorporation, dated June 12, 1997. (3)b By-Laws, as amended November 22, 1996, incorporated by reference to Exhibit No. 4.2 of the Corporation's Registration Statement on Form S- 8 filed with the Securities and Exchange Commission on December 6, 1996 (File No. 33-17367). (4) Copies of instruments defining the rights of holders of long-term debt will be furnished to the Securities and Exchange Commission upon request. (11) The following statement is filed as an exhibit to Part I of this Form 10-Q: The net income per common share computations included in the Consolidated Income Statement in Part 1, Item I, of this Form 10-Q are based on average number of shares of common stock outstanding. The only "common stock equivalents" or other potentially dilutive securit- ies or agreements (as defined in Accounting Principles Board Opinion No. 15) which were contained in the Corporation's capital structure during the periods presented were options outstanding under the Corporation's Equity Participation Plans. Alternative computations of "primary" and "fully diluted" net income per share amounts for 1997 and 1996 assume the exercise of outstanding stock options using the "treasury stock method." There is no significant difference between net income per share presented in Item 1 and net income per share calculated on a "primary" and "fully diluted" basis for the second quarter and first six months of 1997 and 1996. 16 (12) The following computation is filed as an exhibit to Part I of this Form 10-Q: KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES Computation of Ratio of Earnings to Fixed Charges ($ Millions) Six Months Ended June 30 ------------------------ 1997 1996 -------------------------------------------------------------------- Consolidated Companies Income before income taxes ............. $ 983.6 $ 966.5 Interest expense ....................... 83.3 102.1 Interest factor in rent expense ........ 24.8 13.6 Amortization of capitalized interest ... 4.3 4.2 Equity Affiliates Share of 50%-owned: Income before income taxes ............ 27.8 20.1 Interest expense ...................... 3.7 4.7 Interest factor in rent expense ....... .3 .4 Amortization of capitalized interest .. .4 .4 Distributed income of less than 50%-owned 15.7 12.2 -------- -------- Earnings ................................... $1,143.9 $1,124.2 ======== ======== Consolidated Companies Interest expense ....................... $ 83.3 $ 102.1 Capitalized interest ................... 9.7 8.0 Interest factor in rent expense ........ 24.8 13.6 Equity Affiliates Share of 50%-owned: Interest expense and capitalized interest 3.7 4.7 Interest factor in rent expense........ .3 .4 -------- -------- Fixed charges............................... $ 121.8 $ 128.8 ======== ======== Ratio of earnings to fixed charges ... 9.39 8.73 ======== ======== (27) The Financial Data Schedule required by Item 601(b)(27) of Regulation S-K has been included with the electronic filing of this Form 10-Q. (b) Reports on Form 8-K None. 17 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. KIMBERLY-CLARK CORPORATION (Registrant) By: /s/ John W. Donehower ---------------------------- John W. Donehower Senior Vice President and Chief Financial Officer (principal financial officer) By: /s/ Randy J. Vest ------------------------------ Randy J. Vest Vice President and Controller (principal accounting officer) August 7, 1997 18



                                    RESTATED

                          CERTIFICATE OF INCORPORATION

                                       OF

                           KIMBERLY-CLARK CORPORATION

                                 JUNE 12, 1997



                     RESTATED CERTIFICATE OF INCORPORATION

                                       OF

                           KIMBERLY-CLARK CORPORATION

     The date of filing of the original certificate of incorporation of this
Corporation with the Secretary of State was June 29, 1928.

                                   ARTICLE I

     The name of this Corporation is KIMBERLY-CLARK CORPORATION.

                                   ARTICLE II

     Its registered office in the State of Delaware is located at Corporation
Trust Center, 1209 Orange Street, in the City of Wilmington, County of New
Castle. The name and address of its registered agent is The Corporation Trust
Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware
19801.

                                  ARTICLE III

     The purpose of the Corporation is to engage in any lawful act or activity
for which corporations may be organized under the General Corporation Law of
Delaware. The Corporation shall possess and may exercise all powers and
privileges necessary or convenient to effect such purpose and all powers and
privileges now or hereafter conferred by the laws of Delaware upon corporations
formed under the General Corporation Law of Delaware.

                                   ARTICLE IV

     The total number of shares of all classes of capital stock which the
Corporation shall have the authority to issue is one billion, two hundred and
twenty million (1,220,000,000) shares which shall be divided into two classes as
follows:

     (a) Twenty million (20,000,000) shares of Preferred Stock without par
         value; and

     (b) One billion, two hundred million (1,200,000,000) shares of Common Stock
         of the par value of One Dollar and Twenty-five Cents ($1.25) per share.

                                   ARTICLE V

     A statement of the voting powers and of the designations, preferences and
relative, participating, optional or other special rights, and the
qualifications, limitations and restrictions thereof, of each class of stock of
the Corporation, is as follows:

    (1) In General

          No holders of shares of this Corporation of any class, or of bonds,
     debentures or other securities convertible into stock of any class, shall
     be entitled as of right to subscribe for, purchase, or receive any stock of
     any class whether now or hereafter authorized, or any bonds, debentures or
     other securities whether now or hereafter authorized, convertible into
     stock of any class, or any stock into which said bonds, debentures or other
     securities may be convertible, and all such additional shares of stock,
     debentures or other securities, together with the stock into which the same
     may be converted, may be issued and disposed of by the Board of Directors
     to such persons and on such terms and for such consideration (as far as may
     be permitted by law) as the Board of Directors in their absolute discretion
     may deem advisable.



          All persons who shall acquire stock in the Corporation shall acquire
     the same subject to the provisions of this Certificate of Incorporation.

    (2) Preferred Stock

          The Preferred Stock may be issued from time to time in one or more
     series, with such distinctive serial designations as may be stated or
     expressed in the resolution or resolutions providing for the issue of such
     stock adopted from time to time by the Board of Directors; and in such
     resolution or resolutions providing for the issue of shares of each
     particular series, the Board of Directors is also expressly authorized to
     fix: the consideration for which the shares of such series are to be
     issued; the number of shares constituting such series; the rate of
     dividends upon which and the times at which dividends on shares of such
     series shall be payable and the preference, if any, which such dividends
     shall have relative to dividends on shares of any other class or classes or
     any other series of stock of the Corporation; whether such dividends shall
     be cumulative or noncumulative, and if cumulative, the date or dates from
     which dividends on shares of such series shall be cumulative; the voting
     rights, if any, to be provided for shares of such series; the rights, if
     any, which the holders of shares of such series shall have in the event of
     any voluntary or involuntary liquidation, dissolution or winding up of the
     affairs of the Corporation; the rights, if any, which the holders of shares
     of such series shall have to convert such shares into or exchange such
     shares for shares of any other class or classes or any other series of
     stock of the Corporation and the terms and conditions, including price and
     rate of exchange, of such conversion or exchange; the redemption price or
     prices and other terms of redemption, if any, for shares of such series;
     and any and all other preferences and relative, participating, optional or
     other special rights and qualifications, limitations or restrictions
     thereof pertaining to shares of such series.

    (3) Common Stock

          (a) Subject to preferences and rights to which holders of stock other
     than the Common Stock may have become entitled by resolution or resolutions
     of the Board of Directors as hereinbefore provided, such dividends (payable
     in cash, stock, or otherwise) as may be determined by the Board of
     Directors may be declared and paid out of funds legally available therefor
     upon the Common Stock from time to time.

          (b) In the event of any liquidation, dissolution or winding up of the
     affairs of the Corporation, the holders of the Common Stock shall be
     entitled to share ratably in all assets available for distribution to the
     shareholders, subject to preferences and rights to which the holders of
     stock other than the Common Stock may have become entitled by resolution or
     resolutions of the Board of Directors as hereinbefore provided.

          (c) The holders of Common Stock shall be entitled to one vote for each
     of the shares held by them of record at the time for determining holders
     thereof entitled to vote.

    (4) Series A Junior Participating Preferred Stock

          Pursuant to authority conferred by this Article V upon the Board of
     Directors of the Corporation, the Board of Directors created a series of
     2,000,000 shares of Preferred Stock designated as Series A Junior
     Participating Preferred Stock by filing an Amended Certificate of
     Designations of the Corporation with the Secretary of State of the State of
     Delaware on July 12, 1995, and the voting powers, designations, preferences
     and relative, participating and other special rights, and the
     qualifications, limitations and restrictions thereof, of the Series A
     Junior Participating Preferred Stock of the Corporation are as set forth in
     Annex 1 hereto and are incorporated herein by reference.

                                        2



                                   ARTICLE VI

     (1) The following corporate action shall require the approval, given at a
stockholders' meeting or by consent in writing, of the holders of at least
two-thirds of the stock issued and outstanding and entitled to vote thereon:

          (a) the dissolution of the Corporation, or

          (b) the sale, lease, exchange or conveyance of all or substantially
     all of the property and assets of the Corporation, or

          (c) the adoption of an agreement of merger or consolidation, but no
     stockholder approval shall be required for any merger or consolidation
     which, under the Laws of Delaware, need not be approved by the stockholders
     of the Corporation.

     (2) The number of authorized shares of any class or classes of stock may be
increased or decreased by the approval of the holders of a majority of all of
the stock of the Corporation entitled to vote thereon, except to the extent
that, in the resolution or resolutions providing for the issuance of a class or
series of stock, the Board of Directors shall specify that approval of the
holders of one or more classes or series of stock shall be required to increase
or decrease the number of authorized shares of one or more classes or series of
stock.

     (3) Any action required or permitted to be taken by the stockholders of the
Corporation must be effected at a duly called annual or special meeting of
stockholders of the Corporation and may not be effected by any consent in
writing by such stockholders, except for stockholder approvals required by
Section (1) of this Article VI.

     (4) Meetings of stockholders of the Corporation may be called only by the
Board of Directors pursuant to a resolution adopted by the affirmative vote of a
majority of the entire Board of Directors, by the Chairman of the Board, or by
the Chief Executive Officer.

                                  ARTICLE VII

     The private property of the stockholders of the Corporation shall not be
subject to the payment of corporate debts to any extent whatever.

                                  ARTICLE VIII

     (1) Power of the Board of Directors. The business and affairs of the
Corporation shall be managed under the direction of its Board of Directors. In
furtherance, and not in limitation, of the powers conferred by the laws of the
State of Delaware, the Board of Directors is expressly authorized:

          (a) to make, alter, amend or repeal the By-Laws of the Corporation;
     provided, however, that no By-Laws hereafter adopted shall invalidate any
     prior act of the Directors that would have been valid if such By-Laws had
     not been adopted;

          (b) to determine the rights, powers, duties, rules and procedures that
     affect the power of the Board of Directors to direct the business and
     affairs of the Corporation, including the power to designate and empower
     committees of the Board of Directors, to elect, appoint and empower the
     officers and other agents of the Corporation, and to determine the time and
     place of, and the notice requirements for, Board meetings, as well as
     quorum and voting requirements (except as otherwise provided in this
     Certificate of Incorporation) for, and the manner of taking, Board action;
     and

          (c) to exercise all such powers and do all such acts as may be
     exercised by the Corporation, subject to the provisions of the laws of the
     State of Delaware, this Certificate of Incorporation, and any By-Laws of
     the Corporation.

                                        3



     (2) Number of Directors. The number of Directors constituting the entire
Board of Directors shall be not less than 11 nor more than 25. The specific
number of Directors constituting the entire Board of Directors shall be as
authorized from time to time exclusively by the affirmative vote of a majority
of the entire Board of Directors. As used in this Certificate of Incorporation,
the term "entire Board of Directors" means the total authorized number of
Directors that the Corporation would have if there were no vacancies.

     (3) Classified Board. At the 1986 Annual Meeting of Stockholders, the
Directors shall be divided into three classes, with respect to the time that
they severally hold office, as nearly equal in number as possible, with the
initial term of office of the first class of Directors to expire at the 1987
Annual Meeting of Stockholders, the initial term of office of the second class
of Directors to expire at the 1988 Annual Meeting of Stockholders and the
initial term of office of the third class of Directors to expire at the 1989
Annual Meeting of Stockholders. Commencing with the 1987 Annual Meeting of
Stockholders, Directors elected to succeed those Directors whose terms have
thereupon expired shall be elected for a term of office to expire at the third
succeeding Annual Meeting of Stockholders after their election, and upon the
election and qualification of their successors. A person elected as a Director
shall be deemed a Director as of the time of such election. If the number of
Directors is changed, any increase or decrease shall be apportioned among the
classes so as to maintain or attain, if possible, an equal number of Directors
in each class, but in no case will a decrease in the number of Directors shorten
the term of any incumbent Director. If such equality is not possible, the
increase or decrease shall be apportioned among the classes in such a way that
the difference in the number of Directors in any two classes shall not exceed
one.

     (4) Nominations. Subject to the rights of holders of any series of
Preferred Stock or any other class of capital stock of the Corporation (other
than the Common Stock) then outstanding, nominations for the election of
Directors may be made by the affirmative vote of a majority of the entire Board
of Directors or by any stockholder of record entitled to vote generally in the
election of Directors. However, any stockholder of record entitled to vote
generally in the election of Directors may nominate one or more persons for
election as Directors at a meeting only if a written notice of such
stockholder's intent to make such nomination or nominations, meeting the
requirements described below, has been given, either by personal delivery or by
United States mail, postage prepaid, to the Secretary of the Corporation, and
received by the Corporation, not less than 50 days nor more than 75 days prior
to the meeting; provided, however, that in the event that less than 60 days'
notice or prior public disclosure of the date of the meeting is given or made to
stockholders, notice by the stockholder to be timely must be so received not
later than the close of business on the 10th day following the day on which such
notice of the date of meeting was mailed or such public disclosure was made,
whichever first occurs. Each such notice to the Secretary shall set forth: (i)
the name and address of record of the stockholder who intends to make the
nomination; (ii) a representation that the stockholder is a holder of record of
shares of the Corporation entitled to vote at such meeting and intends to appear
in person or by proxy at the meeting to nominate the person or persons specified
in the notice; (iii) the name, age, business and residence addresses, and
principal occupation or employment of each nominee; (iv) a description of all
arrangements or understandings between the stockholder and each nominee and any
other person or persons (naming such person or persons) pursuant to which the
nomination or nominations are to be made by the stockholder; (v) such other
information regarding each nominee proposed by such stockholder as would be
required to be included in a proxy statement filed pursuant to the proxy rules
of the Securities and Exchange Commission; and (vi) the consent of each nominee
to serve as a Director of the Corporation if so elected. The Corporation may
require any proposed nominee to furnish such other information as may reasonably
be required by the Corporation to determine the eligibility of such proposed
nominee to serve as a Director of the Corporation. The presiding officer of the
meeting may, if the facts warrant, determine that a nomination was not made in
accordance with the foregoing procedure, and if he should so determine, he shall
so declare to the meeting and the defective nomination shall be disregarded.

                                        4



     (5) Vacancies. Subject to the rights of the holders of any series of
Preferred Stock or any other class of capital stock of the Corporation (other
than the Common Stock) then outstanding, any vacancies in the Board of Directors
for any reason and any newly created Directorships resulting by reason of any
increase in the number of Directors may, if occurring prior to the expiration of
the term of office of the class in which such vacancy or increase occurs, be
filled only by the Board of Directors, acting by the affirmative vote of a
majority of the remaining Directors then in office, although less than a quorum,
and any Directors so elected shall hold office until the next election of the
class for which such Directors have been elected and until their successors are
elected and qualified.

     (6) Removal of Directors. Subject to the rights of the holders of any
series of Preferred Stock or any other class of capital stock of the Corporation
(other than the Common Stock) then outstanding, (i) any Director, or the entire
Board of Directors, may be removed from office at any time prior to the
expiration of his or their term of office, but only for cause and only by the
affirmative vote of the holders of record of outstanding shares representing at
least eighty percent (80%) of the voting power of all of the shares of capital
stock of the Corporation then entitled to vote generally in the election of
Directors, voting together as a single class, and (ii) any Director may be
removed from office by the affirmative vote of a majority of the entire Board of
Directors, at any time prior to the expiration of his term of office, but only
for cause.

                                   ARTICLE IX

     Whenever a compromise or arrangement is proposed between this Corporation
and its creditors or any class of them and/or between this Corporation and its
stockholders or any class of them, any court of equitable jurisdiction within
the State of Delaware may, on the application in a summary way of this
Corporation or of any creditor or stockholder thereof, or on the application of
any receiver or receivers appointed for this Corporation under the provisions of
section 291 of Title 8 of the Delaware Code or on the application of trustees in
dissolution or of any receiver or receivers appointed for this Corporation under
the provisions of section 279 of Title 8 of the Delaware Code order a meeting of
the creditors or class of creditors, and/or of the stockholders or class of
stockholders of this Corporation, as the case may be, to be summoned in such
manner as the said Court directs. If a majority in number representing
three-fourths in value of the creditors or class of creditors, and/or of the
stockholders or class of stockholders of this Corporation, as the case may be,
agree to any compromise or arrangement and to any reorganization of this
Corporation as a consequence of such compromise or arrangement, the said
compromise or arrangement and the said reorganization shall, if sanctioned by
the Court to which the said application has been made, be binding on all the
creditors or class of creditors, and/or on all the stockholders or class of
stockholders, of this Corporation, as the case may be, and also on this
Corporation.

                                   ARTICLE X

     (1) Certain Definitions. For the purposes of this Article X and the second
proviso of Article XI:

          A. "Business Combination" means:

             (i) any merger or consolidation of the Corporation or any
        Subsidiary with (a) an Interested Stockholder or (b) any other Person
        (whether or not itself an Interested Stockholder) which is, or after
        such merger or consolidation would be, an Affiliate or Associate of an
        Interested Stockholder; or

             (ii) any sale, lease, exchange, mortgage, pledge, transfer or other
        disposition (in one transaction or a series of transactions) to or with,
        or proposed by or on behalf of, an Interested Stockholder or an
        Affiliate or Associate of an Interested Stockholder of any assets of the
        Corporation or any Subsidiary having an aggregate Fair Market Value of
        not less than one percent (1%) of the total assets of the Corporation as
        reported in the

                                        5



        consolidated balance sheet of the Corporation as of the end of the most
        recent quarter with respect to which such balance sheet has been
        prepared; or

             (iii) the issuance or transfer by the Corporation or any Subsidiary
        (in one transaction or a series of transactions) of any securities of
        the Corporation or any Subsidiary to, or proposed by or on behalf of, an
        Interested Stockholder or an Affiliate or Associate of an Interested
        Stockholder in exchange for cash, securities or other property (or a
        combination thereof) having an aggregate Fair Market Value of not less
        than one percent (1%) of the total assets of the Corporation as reported
        in the consolidated balance sheet of the Corporation as of the end of
        the most recent quarter with respect to which such balance sheet has
        been prepared; or

             (iv) the adoption of any plan or proposal for the liquidation or
        dissolution of the Corporation, or any spin-off or split-up of any kind
        of the Corporation or any Subsidiary, proposed by or on behalf of an
        Interested Stockholder or an Affiliate or Associate of an Interested
        Stockholder; or

             (v) any reclassification of securities (including any reverse stock
        split), or recapitalization of the Corporation, or any merger or
        consolidation of the Corporation with any Subsidiary or any other
        transaction (whether or not with or into or otherwise involving an
        Interested Stockholder) which has the effect, directly or indirectly, of
        increasing the percentage of the outstanding shares of (a) any class of
        equity securities of the Corporation or any Subsidiary or (b) any class
        of securities of the Corporation or any Subsidiary convertible into
        equity securities of the Corporation or any Subsidiary, represented by
        securities of such class which are directly or indirectly owned by an
        Interested Stockholder and all of its Affiliates and Associates; or

             (vi) any agreement, contract or other arrangement providing for any
        one or more of the actions specified in clauses (i) through (v) of this
        Section (1)A.

          B. "Affiliate" or "Associate" have the respective meanings ascribed to
     such terms in Rule 12b-2 of the General Rules and Regulations under the
     Securities Exchange Act of 1934, as amended (the "Exchange Act"), as in
     effect on January 1, 1986.

          C. "Beneficial Owner" has the meaning ascribed to such term in Rule
     13d-3 of the General Rules and Regulations under the Exchange Act, as in
     effect on January 1, 1986.

          D. "Continuing Director" means: (i) any member of the Board of
     Directors of the Corporation who (a) is neither the Interested Stockholder
     involved in the Business Combination as to which a vote of Continuing
     Directors is provided hereunder, nor an Affiliate, Associate, employee,
     agent, or nominee of such Interested Stockholder, or the relative of any of
     the foregoing, and (b) was a member of the Board of Directors of the
     Corporation prior to the time that such Interested Stockholder became an
     Interested Stockholder; and (ii) any successor of a Continuing Director
     described in clause (i) who is recommended or elected to succeed a
     Continuing Director by the affirmative vote of a majority of Continuing
     Directors then on the Board of Directors of the Corporation.

          E. "Fair Market Value" means: (i) in the case of stock, the highest
     closing sale price during the 30-day period immediately preceding the date
     in question of a share of such stock on the Composite Tape for New York
     Stock Exchange-Listed Stocks, or, if such stock is not reported on the
     Composite Tape, on the New York Stock Exchange, or, if such stock is not
     listed on such Exchange, on the principal United States securities exchange
     registered under the Exchange Act on which such stock is listed, or, if
     such stock is not listed on any such exchange, the highest closing bid
     quotation with respect to a share of such stock during the 30-day period
     preceding the date in question on the National Association of Securities
     Dealers, Inc. Automated Quotations System or any similar interdealer
     quotation system then in use, or, if

                                        6



     no such quotation is available, the fair market value on the date in
     question of a share of such stock as determined by a majority of the
     Continuing Directors in good faith; and (ii) in the case of property other
     than cash or stock, the fair market value of such property on the date in
     question as determined by a majority of the Continuing Directors in good
     faith.

          F. "Interested Stockholder" means any Person (other than the
     Corporation or any Subsidiary, any employee benefit plan maintained by the
     Company or any Subsidiary or any trustee or fiduciary with respect to any
     such plan when acting in such capacity) who or which:

             (i) is, or was at any time within the two-year period immediately
        prior to the date in question, the Beneficial Owner of five percent (5%)
        or more of the voting power of the then outstanding Voting Stock of the
        Corporation; or

             (ii) is an assignee of, or has otherwise succeeded to, any shares
        of Voting Stock of the Corporation of which an Interested Stockholder
        was the Beneficial Owner at any time within the two-year period
        immediately prior to the date in question, if such assignment or
        succession shall have occurred in the course of a transaction, or series
        of transactions, not involving a public offering within the meaning of
        the Securities Act of 1933, as amended.

          For the purpose of determining whether a Person is an Interested
     Stockholder, the outstanding Voting Stock of the Corporation shall include
     unissued shares of Voting Stock of the Corporation of which the Interested
     Stockholder is the Beneficial Owner but shall not include any other shares
     of Voting Stock of the Corporation which may be issuable pursuant to any
     agreement, arrangement or understanding, or upon the exercise of conversion
     rights, warrants or options, or otherwise, to any Person who is not the
     Interested Stockholder.

          G. A "Person" means any individual, partnership, firm, corporation,
     association, trust, unincorporated organization or other entity, as well as
     any syndicate or group deemed to be a person under Section 14(d)(2) of the
     Exchange Act.

          H. "Subsidiary" means any corporation of which the Corporation owns,
     directly or indirectly, (i) a majority of the outstanding shares of equity
     securities of such corporation, or (ii) shares having a majority of the
     voting power represented by all of the outstanding shares of Voting Stock
     of such corporation. For the purpose of determining whether a corporation
     is a Subsidiary, the outstanding Voting Stock and shares of equity
     securities thereof shall include unissued shares of which the Corporation
     is the Beneficial Owner but shall not include any other shares of Voting
     Stock of the corporation which may be issuable pursuant to any agreement,
     arrangement or understanding, or upon the exercise of conversion rights,
     warrants or options, or otherwise, to any Person who is not the
     corporation.

          I. "Voting Stock" means outstanding shares of capital stock of the
     relevant corporation entitled to vote generally in the election of
     Directors.

     (2) Higher Vote for Business Combinations. In addition to any affirmative
vote required by law or by this Certificate of Incorporation, and except as
otherwise expressly provided in Section (3) of this Article, any Business
Combination shall require the affirmative vote of the holders of record of
outstanding shares representing at least eighty percent (80%) of the voting
power of the then outstanding shares of the Voting Stock of the Corporation,
voting together as a single class, voting at a stockholders' meeting and not by
consent in writing. Such affirmative vote shall be required notwithstanding the
fact that no vote may be required, or that a lesser percentage may be specified,
by law or in any agreement with any national securities exchange or otherwise.

     (3) When Higher Vote Is Not Required. The provisions of Section (2) of this
Article shall not be applicable to any particular Business Combination, and such
Business Combination shall require only such affirmative vote, if any, of the
stockholders as is required by law and any other provision of

                                        7



this Certificate of Incorporation, if the conditions specified in either of the
following paragraphs A and B are met.

          A. Approval by Continuing Directors. The Business Combination shall
     have been approved by the affirmative vote of a majority of the Continuing
     Directors, even if the Continuing Directors do not constitute a quorum of
     the entire Board of Directors.

          B. Form of Consideration, Price and Procedure Requirements. All of the
     following conditions shall have been met:

             (i) With respect to each share of each class of Voting Stock of the
        Corporation (including Common Stock), the holder thereof shall be
        entitled to receive on or before the date of the consummation of the
        Business Combination (the "Consummation Date"), consideration, in the
        form specified in subsection (3)(B)(ii) hereof, with an aggregate Fair
        Market Value as of the Consummation Date at least equal to the highest
        of the following:

                 (a) the highest per share price (including any brokerage
            commissions, transfer taxes and soliciting dealers' fees) paid by
            the Interested Stockholder to which the Business Combination
            relates, or by any Affiliate or Associate of such Interested
            Stockholder, for any shares of such class of Voting Stock acquired
            by it (1) within the two-year period immediately prior to the first
            public announcement of the proposal of the Business Combination (the
            "Announcement Date") or (2) in the transaction in which it became an
            Interested Stockholder, whichever is higher;

                 (b) the Fair Market Value per share of such class of Voting
            Stock of the Corporation on the Announcement Date; and

                 (c) the highest preferential amount per share, if any, to which
            the holders of shares of such class of Voting Stock of the
            Corporation are entitled in the event of any voluntary or
            involuntary liquidation, dissolution or winding up of the
            Corporation.

             (ii) The consideration to be received by holders of a particular
        class of outstanding Voting Stock of the Corporation (including Common
        Stock) as described in subsection (3)(B)(i) hereof shall be in cash or
        if the consideration previously paid by or on behalf of the Interested
        Stockholder in connection with its acquisition of beneficial ownership
        of shares of such class of Voting Stock consisted in whole or in part of
        consideration other than cash, then in the same form as such
        consideration. If such payment for shares of any class of Voting Stock
        of the Corporation has been made in varying forms of consideration, the
        form of consideration for such class of Voting Stock shall be either
        cash or the form used to acquire the beneficial ownership of the largest
        number of shares of such class of Voting Stock previously acquired by
        the Interested Stockholder.

             (iii) After such Interested Stockholder has become an Interested
        Stockholder and prior to the Consummation Date: (a) except as approved
        by the affirmative vote of a majority of the Continuing Directors, there
        shall have been no failure to declare and pay at the regular date
        therefor any full quarterly dividends (whether or not cumulative) on the
        outstanding Preferred Stock of the Corporation, if any; (b) there shall
        have been (1) no reduction in the annual rate of dividends paid on the
        Common Stock of the Corporation (except as necessary to reflect any
        subdivision of the Common Stock), except as approved by the affirmative
        vote of a majority of the Continuing Directors, and (2) an increase in
        such annual rate of dividends as necessary to reflect any
        reclassification (including any reverse stock split), recapitalization,
        reorganization or any similar transaction which has the effect of
        reducing the number of outstanding shares of Common Stock, unless the
        failure so to increase such annual rate is approved by the affirmative
        vote of a majority of the Continuing Directors; and (c) such Interested
        Stockholder shall not have

                                        8



        become the Beneficial Owner of any additional shares of Voting Stock of
        the Corporation except as part of the transaction which results in such
        Interested Stockholder becoming an Interested Stockholder.

             (iv) After such Interested Stockholder has become an Interested
        Stockholder, neither such Interested Stockholder nor any Affiliate or
        Associate thereof shall have received the benefit, directly or
        indirectly (except proportionately as a stockholder of the Corporation),
        of any loans, advances, guarantees, pledges or other financial
        assistance or any tax credits or other tax advantages provided by the
        Corporation.

             (v) A proxy or information statement describing the proposed
        Business Combination and complying with the requirements of the Exchange
        Act and the General Rules and Regulations thereunder (or any subsequent
        provisions replacing such Act, rules or regulations) shall be mailed to
        the stockholders of the Corporation at least 45 days prior to the
        consummation of such Business Combination (whether or not such proxy or
        information statement is required to be mailed pursuant to such Act or
        subsequent provisions thereof).

     (4) Powers of Continuing Directors. A majority of the Continuing Directors
shall have the power and duty to determine, on the basis of information known to
them after reasonable inquiry, all facts necessary to determine compliance with
this Article, including, without limitation, (A) whether a Person is an
Interested Stockholder, (B) the number of shares of Voting Stock of the
Corporation beneficially owned by any Person, (C) whether a Person is an
Affiliate or Associate of another, (D) whether the requirements of paragraph B
of Section (3) have been met with respect to any Business Combination, and (E)
whether the assets which are the subject of any Business Combination have, or
the consideration to be received for the issuance or transfer of securities by
the Corporation or any Subsidiary in any Business Combination has, an aggregate
Fair Market Value of not less than one percent (1%) of the total assets of the
Corporation as reported in the consolidated balance sheet of the Corporation as
of the end of the most recent quarter with respect to which such balance sheet
has been prepared; and the good faith determination of a majority of the
Continuing Directors on such matters shall be conclusive and binding for all the
purposes of this Article.

     (5) No Effect on Fiduciary Obligations.

          A. Nothing contained in this Article shall be construed to relieve the
     members of the Board of Directors or an Interested Stockholder from any
     fiduciary obligation imposed by law.

          B. The fact that any Business Combination complies with the provisions
     of Section (3) of this Article shall not be construed to impose any
     fiduciary duty, obligation or responsibility on the Board of Directors, or
     any member thereof, to approve such Business Combination or recommend its
     adoption or approval to the stockholders of the Corporation, nor shall such
     compliance limit, prohibit or otherwise restrict in any manner the Board of
     Directors, or any member thereof, with respect to evaluations of or actions
     and responses taken with respect to such Business Combination.

     (6) Effect on Other Provisions. The provisions of this Article X are in
addition to, and shall not alter or amend, the provisions of Section (1) of
Article VI of this Certificate of Incorporation.

                                   ARTICLE XI

     The Corporation reserves the right to amend, alter, change or repeal any
provision contained in this Certificate of Incorporation in the manner now or
hereafter prescribed by law, and all rights and powers conferred herein on
stockholders, directors and officers are subject to this reserved power;
provided that, notwithstanding the fact that a lesser percentage may be
specified by the General

                                        9



Corporation Law of Delaware, the affirmative vote of the holders of record of
outstanding shares representing at least eighty percent (80%) of the voting
power of all of the shares of capital stock of the Corporation then entitled to
vote generally in the election of Directors, voting together as a single class,
shall be required to amend, alter, change, repeal, or adopt any provision or
provisions inconsistent with, Section (2) of Article V, Sections (3) and (4) of
Article VI, and Articles VIII and XI (except for the second proviso of this
Article XI) of this Certificate of Incorporation unless such amendment,
alteration, change, repeal or adoption of any inconsistent provision or
provisions is declared advisable by the Board of Directors by the affirmative
vote of at least seventy-five percent (75%) of the entire Board of Directors;
and provided further that, notwithstanding the fact that a lesser percentage may
be specified by the General Corporation Law of Delaware, the affirmative vote of
the holders of record of outstanding shares representing at least eighty percent
(80%) of the voting power of all the outstanding Voting Stock of the
Corporation, voting together as a single class, shall be required to amend,
alter or repeal, or adopt any provision or provisions inconsistent with, any
provision of Article X or this proviso of this Article XI, unless such
amendment, alteration, repeal, or adoption of any inconsistent provision or
provisions is declared advisable by the Board of Directors by the affirmative
vote of at least seventy-five percent (75%) of the entire Board of Directors and
by a majority of the Continuing Directors.

                                  ARTICLE XII

     No Director shall be personally liable to the Corporation or its
stockholders for monetary damages for any breach of fiduciary duty by such
Director as a Director. Notwithstanding the foregoing, a Director shall be
liable to the extent provided by applicable law (i) for breach of the Director's
duty of loyalty to the Corporation or its stockholders, (ii) for acts or
omissions not in good faith or which involve intentional misconduct or a knowing
violation of law, (iii) pursuant to Section 174 of the General Corporation Law
of the State of Delaware or (iv) for any transaction from which the Director
derived an improper personal benefit. No amendment to or repeal of these
provisions shall apply to or have any effect on the liability or alleged
liability of any Director of the Corporation for or with respect to any acts or
omissions of such Director occurring prior to such amendment or repeal.

                                       10



                                                                         ANNEX 1

                                    AMENDED

                          CERTIFICATE OF DESIGNATIONS

                                       OF

                 SERIES A JUNIOR PARTICIPATING PREFERRED STOCK

                                       OF

                           KIMBERLY-CLARK CORPORATION

                        (PURSUANT TO SECTION 151 OF THE

                       DELAWARE GENERAL CORPORATION LAW)

     Kimberly-Clark Corporation, a corporation organized and existing under the
General Corporation Law of the State of Delaware (hereinafter called the
"Corporation"), hereby certifies that (i) a Certificate of Designations for the
Series A Participating Preferred Stock of the Corporation (the "Preferred
Stock") was filed with the Secretary of State of the State of Delaware on July
1, 1988, (ii) no shares of the Preferred Stock have been issued or are
outstanding, and (iii) the Board of Directors of the Corporation adopted the
following resolution amending in their entireties the voting powers, preferences
and relative, participating, optional and other special rights of the Preferred
Stock as the following resolution was adopted by the Board of Directors of the
Corporation as required by Section 151 of the General Corporation Law at a
meeting duly called and held on June 8, 1995:

     RESOLVED, that pursuant to the authority granted to and vested in the Board
of Directors of this Corporation (hereinafter called the "Board of Directors" or
the "Board") in accordance with the provisions of the Certificate of
Incorporation, the Board of Directors hereby amends the provisions of the Series
A Junior Participating Preferred Stock of the Corporation to state the
designation and number of shares, and to fix the relative rights, preferences,
and limitations thereof as follows:

     Series A Junior Participating Preferred Stock:

     Section 1. Designation and Amount. The shares of such series shall be
designated as "Series A Junior Participating Preferred Stock" (the "Series A
Preferred Stock") and the number of shares constituting the Series A Preferred
Stock shall be 2,000,000. Such number of shares may be increased or decreased by
resolution of the Board of Directors; provided, that no decrease shall reduce
the number of shares of Series A Preferred Stock to a number less than the
number of shares then outstanding plus the number of shares reserved for
issuance upon the exercise of outstanding options, rights or warrants or upon
the conversion of any outstanding securities issued by the Corporation
convertible into Series A Preferred Stock.

     Section 2. Dividends and Distributions.

          (A) Subject to the rights of the holders of any shares of any series
     of Preferred Stock (or any similar stock) ranking prior and superior to the
     Series A Preferred Stock with respect to dividends, the holders of shares
     of Series A Preferred Stock, in preference to the holders of Common Stock,
     par value $1.25 per share (the "Common Stock"), of the Corporation, and of
     any other junior stock, shall be entitled to receive, when, as and if
     declared by the Board of Directors out of funds legally available for the
     purpose, quarterly dividends payable in cash on the first day of March,
     June, September and December in each year (each such date being referred to
     herein as a "Quarterly Dividend Payment Date"), commencing on the first
     Quarterly Dividend Payment Date after the first issuance of a share or
     fraction of a share of Series A

                                       A-1



     Preferred Stock, in an amount per share (rounded to the nearest cent) equal
     to the greater of (a) $1 or (b) subject to the provision for adjustment
     hereinafter set forth, 100 times the aggregate per share amount of all cash
     dividends, and 100 times the aggregate per share amount (payable in kind)
     of all non-cash dividends or other distributions, other than a dividend
     payable in shares of Common Stock or a subdivision of the outstanding
     shares of Common Stock (by reclassification or otherwise), declared on the
     Common Stock since the immediately preceding Quarterly Dividend Payment
     Date or, with respect to the first Quarterly Dividend Payment Date, since
     the first issuance of any share or fraction of a share of Series A
     Preferred Stock. In the event the Corporation shall at any time declare or
     pay any dividend on the Common Stock payable in shares of Common Stock, or
     effect a subdivision or combination or consolidation of the outstanding
     shares of Common Stock (by reclassification or otherwise than by payment of
     a dividend in shares of Common Stock) into a greater or lesser number of
     shares of Common Stock, then in each such case the amount to which holders
     of shares of Series A Preferred Stock were entitled immediately prior to
     such event under clause (b) of the preceding sentence shall be adjusted by
     multiplying such amount by a fraction, the numerator of which is the number
     of shares of Common Stock outstanding immediately after such event and the
     denominator of which is the number of shares of Common Stock that were
     outstanding immediately prior to such event.

          (B) The Corporation shall declare a dividend or distribution on the
     Series A Preferred Stock as provided in paragraph (A) of this Section
     immediately after it declares a dividend or distribution on the Common
     Stock (other than a dividend payable in shares of Common Stock); provided
     that, in the event no dividend or distribution shall have been declared on
     the Common Stock during the period between any Quarterly Dividend Payment
     Date and the next subsequent Quarterly Dividend Payment Date, a dividend of
     $1 per share on the Series A Preferred Stock shall nevertheless be payable
     on such subsequent Quarterly Dividend Payment Date.

          (C) Dividends shall begin to accrue and be cumulative on outstanding
     shares of Series A Preferred Stock from the Quarterly Dividend Payment Date
     next preceding the date of issue of such shares, unless the date of issue
     of such shares is prior to the record date for the first Quarterly Dividend
     Payment Date, in which case dividends on such shares shall begin to accrue
     from the date of issue of such shares, or unless the date of issue is a
     Quarterly Dividend Payment Date or is a date after the record date for the
     determination of holders of shares of Series A Preferred Stock entitled to
     receive a quarterly dividend and before such Quarterly Dividend Payment
     Date, in either of which events such dividends shall begin to accrue and be
     cumulative from such Quarterly Dividend Payment Date. Accrued but unpaid
     dividends shall not bear interest. Dividends paid on the shares of Series A
     Preferred Stock in an amount less than the total amount of such dividends
     at the time accrued and payable on such shares shall be allocated pro rata
     on a share-by-share basis among all such shares at the time outstanding.
     The Board of Directors may fix a record date for the determination of
     holders of shares of Series A Preferred Stock entitled to receive payment
     of a dividend or distribution declared thereon, which record date shall be
     not more than 60 days prior to the date fixed for the payment thereof.

     Section 3. Voting Rights. The holders of shares of Series A Preferred Stock
shall have the following voting rights:

          (A) Subject to the provision for adjustment hereinafter set forth,
     each share of Series A Preferred Stock shall entitle the holder thereof to
     100 votes on all matters submitted to a vote of the stockholders of the
     Corporation. In the event the Corporation shall at any time declare or pay
     any dividend on the Common Stock payable in shares of Common Stock, or
     effect a subdivision or combination or consolidation of the outstanding
     shares of Common Stock (by reclassification or otherwise than by payment of
     a dividend in shares of Common Stock) into a greater or lesser number of
     shares of Common Stock, then in each such case the number of votes per
     share to which holders of shares of Series A Preferred Stock were entitled

                                       A-2



     immediately prior to such event shall be adjusted by multiplying such
     number by a fraction, the numerator of which is the number of shares of
     Common Stock outstanding immediately after such event and the denominator
     of which is the number of shares of Common Stock that were outstanding
     immediately prior to such event.

          (B) Except as otherwise provided herein, in any other Certificate of
     Designations creating a series of Preferred Stock or any similar stock, or
     by law, the holders of shares of Series A Preferred Stock and the holders
     of shares of Common Stock and any other capital stock of the Corporation
     having general voting rights shall vote together as one class on all
     matters submitted to a vote of stockholders of the Corporation.

          (C) Except as set forth herein, or as otherwise provided by law,
     holders of Series A Preferred Stock shall have no special voting rights and
     their consent shall not be required (except to the extent they are entitled
     to vote with holders of Common Stock as set forth herein) for taking any
     corporate action.

     Section 4. Certain Restrictions.

          (A) Whenever quarterly dividends or other dividends or distributions
     payable on the Series A Preferred Stock as provided in Section 2 are in
     arrears, thereafter and until all accrued and unpaid dividends and
     distributions, whether or not declared, on shares of Series A Preferred
     Stock outstanding shall have been paid in full, the Corporation shall not:

             (i) declare or pay dividends, or make any other distributions, on
        any shares of stock ranking junior (either as to dividends or upon
        liquidation, dissolution or winding up) to the Series A Preferred Stock;

             (ii) declare or pay dividends, or make any other distributions, on
        any shares of stock ranking on a parity (either as to dividends or upon
        liquidation, dissolution or winding up) with the Series A Preferred
        Stock, except dividends paid ratably on the Series A Preferred Stock and
        all such parity stock on which dividends are payable or in arrears in
        proportion to the total amounts to which the holders of all such shares
        are then entitled;

             (iii) redeem or purchase or otherwise acquire for consideration
        shares of any stock ranking junior (either as to dividends or upon
        liquidation, dissolution or winding up) to the Series A Preferred Stock,
        provided that the Corporation may at any time redeem, purchase or
        otherwise acquire shares of any such junior stock in exchange for shares
        of any stock of the Corporation ranking junior (either as to dividends
        or upon dissolution, liquidation or winding up) to the Series A
        Preferred Stock; or

             (iv) redeem or purchase or otherwise acquire for consideration any
        shares of Series A Preferred Stock, or any shares of stock ranking on a
        parity with the Series A Preferred Stock, except in accordance with a
        purchase offer made in writing or by publication (as determined by the
        Board of Directors) to all holders of such shares upon such terms as the
        Board of Directors, after consideration of the respective annual
        dividend rates and other relative rights and preferences of the
        respective series and classes, shall determine in good faith will result
        in fair and equitable treatment among the respective series or classes.

          (B) The Corporation shall not permit any subsidiary of the Corporation
     to purchase or otherwise acquire for consideration any shares of stock of
     the Corporation unless the Corporation could, under paragraph (A) of this
     Section 4, purchase or otherwise acquire such shares at such time and in
     such manner.

     Section 5. Reacquired Shares. Any shares of Series A Preferred Stock
purchased or otherwise acquired by the Corporation in any manner whatsoever
shall be retired and cancelled promptly after the acquisition thereof. All such
shares shall upon their cancellation become authorized but unissued shares of
Preferred Stock and may be reissued as part of a new series of Preferred Stock

                                       A-3



subject to the conditions and restrictions on issuance set forth herein, in the
Certificate of Incorporation, or in any other Certificate of Designations
creating a series of Preferred Stock or any similar stock or as otherwise
required by law.

     Section 6. Liquidation, Dissolution or Winding Up. Upon any liquidation,
dissolution or winding up of the Corporation, no distribution shall be made (1)
to the holders of shares of stock ranking junior (either as to dividends or upon
liquidation, dissolution or winding up) to the Series A Preferred Stock unless,
prior thereto, the holders of shares of Series A Preferred Stock shall have
received $100 per share, plus an amount equal to accrued and unpaid dividends
and distributions thereon, whether or not declared, to the date of such payment,
provided that the holders of shares of Series A Preferred Stock shall be
entitled to receive an aggregate amount per share, subject to the provision for
adjustment hereinafter set forth, equal to 100 times the aggregate amount to be
distributed per share to holders of shares of Common Stock, or (2) to the
holders of shares of stock ranking on a parity (either as to dividends or upon
liquidation, dissolution or winding up) with the Series A Preferred Stock,
except distributions made ratably on the Series A Preferred Stock and all such
parity stock in proportion to the total amounts to which the holders of all such
shares are entitled upon such liquidation, dissolution or winding up. In the
event the Corporation shall at any time declare or pay any dividend on the
Common Stock payable in shares of Common Stock, or effect a subdivision or
combination or consolidation of the outstanding shares of Common Stock (by
reclassification or otherwise than by payment of a dividend in shares of Common
Stock) into a greater or lesser number of shares of Common Stock, then in each
such case the aggregate amount to which holders of shares of Series A Preferred
Stock were entitled immediately prior to such event under the proviso in clause
(1) of the preceding sentence shall be adjusted by multiplying such amount by a
fraction the numerator of which is the number of shares of Common Stock
outstanding immediately after such event and the denominator of which is the
number of shares of Common Stock that were outstanding immediately prior to such
event.

     Section 7. Consolidation. Merger. Etc. In case the Corporation shall enter
into any consolidation, merger, combination or other transaction in which the
shares of Common Stock are exchanged for or changed into other stock or
securities, cash and/or any other property, then in any such case each share of
Series A Preferred Stock shall at the same time be similarly exchanged or
changed into an amount per share, subject to the provision for adjustment
hereinafter set forth, equal to 100 times the aggregate amount of stock,
securities, cash and/or any other property (payable in kind), as the case may
be, into which or for which each share of Common Stock is changed or exchanged.
In the event the Corporation shall at any time declare or pay any dividend on
the Common Stock payable in shares of Common Stock, or effect a subdivision or
combination or consolidation of the outstanding shares of Common Stock (by
reclassification or otherwise than by payment of a dividend in shares of Common
Stock) into a greater or lesser number of shares of Common Stock, then in each
such case the amount set forth in the preceding sentence with respect to the
exchange or change of shares of Series A Preferred Stock shall be adjusted by
multiplying such amount by a fraction, the numerator of which is the number of
shares of Common Stock outstanding immediately after such event and the
denominator of which is the number of shares of Common Stock that were
outstanding immediately prior to such event.

     Section 8. No Redemption. The shares of Series A Preferred Stock shall not
be redeemable.

     Section 9. Rank. The Series A Preferred Stock shall rank, with respect to
the payment of dividends and the distribution of assets, junior to all series of
any other class of the Corporation's Preferred Stock.

     Section 10. Amendment. The Certificate of Incorporation of the Corporation
shall not be amended in any manner which would materially alter or change the
powers, preferences or special rights of the Series A Preferred Stock so as to
affect them adversely without the affirmative vote of the holders of at least
two-thirds of the outstanding shares of Series A Preferred Stock, voting
together as a single class.

                                       A-4



     IN WITNESS WHEREOF, this Certificate of Designations is executed on behalf
of the Corporation by its Vice President and Secretary this 12th day of July,
1995.

                                            /s/ DONALD M. CROOK
                                            ------------------------------------
                                            Name: Donald M. Crook
                                            Title: Vice President and Secretary

                                       A-5

 

5 1000 6-MOS DEC-31-1997 JUN-30-1997 90000 0 1602500 0 1319900 3307400 10272000 4290400 11126600 3117100 1668200 0 0 0 0 11126600 6361900 6361900 3928700 5323200 0 0 83300 983600 324600 715000 0 17500 0 732500 1.31 1.31 Items not disclosed since they are not required for interim reporting under regulation S-X, Article 10.